Inactive Instrument
Sector ratings Intercept Pharmaceuticals, Inc. Mexican S.E.
Stocks
ICPT *
US45845P1084
Biotechnology & Medical Research
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 72.12B | AAA | |||||||
| 65.85B | A | |||||||
| 29.28B | - | - | - | - | ||||
| 27.47B | - | A | - | - | ||||
| 26.7B | AAA | |||||||
| 20.06B | A | |||||||
| 18.22B | AA | |||||||
| 16.4B | AA | - | ||||||
| 13.4B | BB | |||||||
| 12.3B | - | BB | - | - | ||||
| 11.94B | - | B | - | - | ||||
| 10.6B | B | - | ||||||
| 10.68B | - | AA | - | - | ||||
| 10.5B | - | - | - | - | ||||
| 9.39B | - | BB | - | - | - | |||
| 8.7B | - | |||||||
| 9.32B | - | BBB | - | - | ||||
| 8.98B | - | BBB | - | - | ||||
| 8.26B | - | CCC | - | - | ||||
| Average | 20.54B | A | |||||||
| Weighted average by Cap. | A |
